Centaur Pharmaceuticals began its journey in Mumbai, establishing itself as a vertically integrated pharmaceutical company. We are hosting a Walk-In Drive at Centaur Pharmaceuticals in Ambernath on Saturday, September 20, 2025, from 10 AM to 4 PM. The venue is located at Plot 75, 76, Chikhloli MIDC Ambernath West. We have exciting job openings in various departments, particularly in Quality Control and Analytical R&D, with positions available for Chemists, Officers, Senior Officers, Executives, Assistant Managers, and Deputy Managers, requiring 2 to 15 years of experience.

Vacancy details

Department: Quality Control (QC)
Role: Chemist/ Officer Sr. Officer/ Executive/ Assistant Manager/ Dy. Manager
Section: Analytical Method Validation/ Analytical R&D
Experience Required: 2 – 15 yrs of relevant experience
Qualification: B.Sc. (Chemistry)

Walk-in interview details

Date of interview: 20th September 2025 (Saturday)
Timings: 10:00 AM to 4:00 PM
Venue: Centaur Pharmaceuticals Private Limited, Plot 75 & 76, Chikhloli MIDC Ambernath – West, Maharashtra – 421505.

Note:

• Additionally, applicants with experience in Production, Safety and ETP, Mechanical, Instrumentation, Electrical Engineering, R&D, and Accounts, specifically in API, can submit their CVs to apihrd@centaurlab.com.
• Candidates with experience in the pharmaceutical industry, particularly those who have worked with regulated and accredited organizations such as the USFDA, EDOM, and MHRA, will be given preference.
• Applicants must be willing to work across all shifts. Interested individuals are encouraged to attend the walk-in interview with their CV and a passport-sized photograph.
• Applicants must be willing to work in all shifts and should attend the walk-in with their CV and a passport-sized photograph.

About Centaur Pharmaceuticals

Centaur Pharmaceuticals is a comprehensive Indian pharmaceutical firm, proficient in all aspects of the pharmaceutical value chain, with a manufacturing plant located in Mumbai, India. The company has been issued warnings concerning compliance with Current Good Manufacturing Practice (CGMP) regulations for its finished pharmaceutical products.